SS Innovations International (SSII) EBIT (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.10% |
| Dec 31, 2025 | -261.17% |
| Sep 30, 2025 | -1,991.76% |
| Jun 30, 2025 | 101.64% |
| Mar 31, 2025 | 61.44% |
| Dec 31, 2024 | -379.23% |
| Sep 30, 2024 | 21.84% |
| Jun 30, 2024 | 58.30% |
| Mar 31, 2024 | 19.14% |
| Dec 31, 2023 | -556.56% |
| Sep 30, 2023 | 64.32% |
| Jun 30, 2023 | -384.87% |
| Mar 31, 2023 | -22.08% |
| Dec 31, 2022 | -106.16% |
| Sep 30, 2022 | 41.33% |
| Jun 30, 2022 | -801.57% |
| Mar 31, 2022 | 77.27% |
| Dec 31, 2021 | 15.42% |
| Sep 30, 2021 | -1.43% |
| Jun 30, 2021 | -37.41% |
| Mar 31, 2021 | -35.31% |
| Dec 31, 2020 | 40.90% |
| Sep 30, 2020 | -70.56% |
| Jun 30, 2020 | 28.27% |
| Mar 31, 2020 | 70.75% |
| Dec 31, 2019 | 24.63% |
| Sep 30, 2019 | -161.21% |
| Jun 30, 2019 | -35.04% |
| Mar 31, 2019 | -79.94% |
| Dec 31, 2018 | 26.28% |
| Sep 30, 2018 | -44.65% |
| Jun 30, 2018 | 13.80% |
| Mar 31, 2018 | 49.70% |
| Dec 31, 2017 | -177.06% |
| Sep 30, 2017 | 4.10% |
| Jun 30, 2017 | 4.77% |
| Mar 31, 2017 | -0.79% |
| Dec 31, 2016 | 21.55% |
| Sep 30, 2016 | -496.68% |